Skip to Main content Skip to Navigation
Journal articles

MST1/Hippo promoter gene methylation predicts poor survival in patients with malignant pleural mesothelioma in the IFCT-GFPC-0701 MAPS Phase 3 trial

Elodie Maille 1, 2 Solenn Brosseau 3 Vincent Hanoux 4 Christian Creveuil 5 Claire Danel 6 Emmanuel Bergot 7, 2 Arnaud Scherpereel 8 Julien Mazières 9 Jacques Margery 10 Laurent Greillier 11, 12 Clarisse Audigier-Valette 13 Denis Moro-Sibilot 14, 15 Olivier Molinier 16 Romain Corre 17 Isabelle Monnet 18 Valérie Gounant 19 Alexandra Langlais 20 Franck Morin 20 Guénaëlle Levallet 7, 2 Gérard Zalcman 21, 22
Document type :
Journal articles
Complete list of metadatas

https://hal-normandie-univ.archives-ouvertes.fr/hal-02103278
Contributor : Florence Couteau <>
Submitted on : Thursday, April 18, 2019 - 11:29:15 AM
Last modification on : Thursday, October 8, 2020 - 4:32:07 PM

Links full text

Identifiers

Citation

Elodie Maille, Solenn Brosseau, Vincent Hanoux, Christian Creveuil, Claire Danel, et al.. MST1/Hippo promoter gene methylation predicts poor survival in patients with malignant pleural mesothelioma in the IFCT-GFPC-0701 MAPS Phase 3 trial. British Journal of Cancer, Cancer Research UK, 2019, 120 (4), pp.387-397. ⟨10.1038/s41416-019-0379-8⟩. ⟨hal-02103278⟩

Share

Metrics

Record views

232